Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics

Annals of the Rheumatic Diseases

Volumn 65, Issue 8, 2006, Pages 1102-1105

  Carli, C ^a,b   Ehlin, A G C ^b   Klareskog, L ^b   Lindblad, S ^a,b   Montgomery, S M ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; GLUCOCORTICOID; METHOTREXATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HOSPITAL CARE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; STATISTICAL ANALYSIS; SWEDEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HOSPITALS; HOSPITALS, DISTRICT; HOSPITALS, UNIVERSITY; HUMANS; LOGISTIC MODELS; MALE; METHOTREXATE; MIDDLE AGED; ODDS RATIO; OUTPATIENT CLINICS, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; RHEUMATOLOGY;

EID: 33746497818     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.027656     Document Type: Article

References (15)

1. Stenger AA, Van Leeuwen MA, Houtman PM, Bruyn GA, Speerstra F, Barendsen BC, et al. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression. Br J Rheumatol 1998;37:1157-63.
2. nd line therapy: 5 year follow-up of a prospective double blind placebo controlled study. J Rheumatol 1995;12:2208-13.
3. van der Heijde DM, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort, van der Veen MJ, et al. The effectiveness of early treatment with "second-line" antirheumatic drugs: a randomised controlled trial. Ann Intern Med 1996;124:699-707.
4. Mottonen T, Hannonen P, Korpela M, Nissila M, Kautiainen H, Ilonen J, et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002;46:894-8.
5. Criswell LA, Henke CJ. What explains the variation among rheumatologists in their use of prednisolone and second line agents for the treatment of rheumatoid arthritis? J Rheumatol 1995;22:829-35.
6. Saraux A, Berthelot JM, Chales G, Le HC, Thorel J, Hoang S, et al. Second-line drugs used in recent-onset rheumatoid arthritis in Brittany (France). Joint Bone Spine 2002;69:37-42.
7. Albers JMC, Paimela L, Kurki P, Eberhardt KB, Emery P, van't Hof MA, et al. Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60:453-8.
8. Galindo-Rodriguez G, Avina-Zubieta JA, Fitzgerald A, LeClerq SA, Russell AS, Suarez-Almazor ME. Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis. J Rheumatol 1997;24:633-8.
9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
10. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993;36:729-40.
11. Ekdahl C, Eberhardt K, Andersson SI, Svensson B. Assessing disability in patients with rheumatoid arthritis. Use of the Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol 1988;17:263-71.
12. Prevoo ML, van Riel PL, van't Hof MA, van Rijswijk MH, van Leeuwen MA, Kuper HH, et al. Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis. Br J Rheumatol 1993;32:589-94.
13. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
14. Norusis MJ. SPSS user's guide. Chicago: SPSS Inc, 1998.
15. Aletaha D, Eberl G, Nell VP, Machold KP, Smolen JS. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years. Ann Rheum Dis 2002;61:630-4.